{"nctId":"NCT02152696","briefTitle":"Optimal Treatment for Women With a Persisting Pregnancy of Unknown Location","startDateStruct":{"date":"2014-07-25","type":"ACTUAL"},"conditions":["Persistent Pregnancy of Unknown Location","Ectopic Pregnancy"],"count":255,"armGroups":[{"label":"Expectant Management","type":"ACTIVE_COMPARATOR","interventionNames":["Other: Expectant Management"]},{"label":"Uterine evacuation with MTX for some","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Methotrexate","Procedure: Uterine Evacuation"]},{"label":"Empiric treatment with MTX for all","type":"ACTIVE_COMPARATOR","interventionNames":["Drug: Methotrexate"]}],"interventions":[{"name":"Methotrexate","otherNames":[]},{"name":"Uterine Evacuation","otherNames":[]},{"name":"Expectant Management","otherNames":[]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion Criteria:\n\n* Female with a persisting pregnancy of unknown location:\n* A pregnancy of unknown location is defined as a pregnancy in a woman with a positive pregnancy test but no definitive signs of pregnancy in the uterus or adnexa on ultrasound imaging. A definitive sign of gestation includes ultrasound visualization of a gestational sac with a yolk sac (with or without an embryo) in the uterus or in the adnexa. Ultrasound must be performed within 7 days prior to randomization.\n* Persistence of hCG is defined as at least 2 serial hCG values (over 2-14 days), showing \\< 15% rise per day, or \\< 50% fall between the first and last value.\n* Patient is hemodynamically stable, hemoglobin \\>10 mg/dL\n* Greater than or 18 years of age\n\nExclusion Criteria:\n\n* Hemodynamically unstable in need of acute treatment\n* Most recent hCG \\> 5000 mIU/mL\n* Patient obtaining care in relation to a recently completed pregnancy (delivery, spontaneous or elective abortion)\n* Diagnosis of gestational trophoblastic disease\n* Subject unwilling or unable to comply with study procedures\n* Known hypersensitivity to MTX\n* Presence of clinical contraindications for treatment with MTX\n* Prior medical or surgical management of this gestation\n* Subject unwilling to accept a blood transfusion","healthyVolunteers":false,"sex":"FEMALE","minimumAge":"18 Years","stdAges":["ADULT","OLDER_ADULT"]},"locations":{"multicenter":true},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Number of Participants With Uneventful Clinical Resolution of a Pregnancy of Unknown Location Without Change From the Initial Management Strategy","description":"The primary outcome measure in each of each 3 treatment arm is the uneventful clinical resolution of a PPUL without change in treatment from the initial management strategy.","paramType":"COUNT_OF_PARTICIPANTS","dispersionType":null,"classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"31","spread":null},{"groupId":"OG001","value":"42","spread":null},{"groupId":"OG002","value":"45","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":2,"n":86},"commonTop":["One or more adverse event","Vaginal bleeding","Pelvic Pain","Fatigue","Nausea"]}}}